VEGF decoy receptor
This page covers all VEGF decoy receptor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting VEGF.
Targets
Phase 3 pipeline (1)
- conbercept, Fixed · Chengdu Kanghong Biotech Co., Ltd. · Ophthalmology
Conbercept is a recombinant human VEGF decoy receptor that inhibits angiogenesis.